Terms: = Endocrine gland cancer AND CARS, P49589, 833, ENSG00000110619 AND Prognosis
19 results:
1. The diagnostic value of ultrasound on different-sized thyroid nodules based on ACR TI-RADS.
Li W; Chen J; Ye F; Xu D; Fan X; Yang C
Endocrine; 2023 Dec; 82(3):569-579. PubMed ID: 37656349
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study.
Leng C; Cui Y; Mai Z; Chen R; Yuan J; Wang K; Wen J; Fu J; Liu Q
Int J Surg; 2023 Sep; 109(9):2574-2584. PubMed ID: 37222675
[TBL] [Abstract] [Full Text] [Related]
3. Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy.
Ju Y; Wang L; Cheng F; Huang F; Chen X; Song Q; Xiao J; Zhu X; Jia H
BMC Endocr Disord; 2023 Jan; 23(1):19. PubMed ID: 36670396
[TBL] [Abstract] [Full Text] [Related]
4. Establishment of the diagnostic and prognostic nomograms for pancreatic cancer with bone metastasis.
Liu Z; Liu H; Wang D
Sci Rep; 2022 Oct; 12(1):18085. PubMed ID: 36302941
[TBL] [Abstract] [Full Text] [Related]
5. A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.
Zhang H; Gao C; Chen J; Wu S; Bai J; Yin T
J Transl Med; 2021 Dec; 19(1):525. PubMed ID: 34952605
[TBL] [Abstract] [Full Text] [Related]
6. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
Li S; Zhu Z
J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
[TBL] [Abstract] [Full Text] [Related]
7. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods.
Paik ES; Lee JW; Park JY; Kim JH; Kim M; Kim TJ; Choi CH; Kim BG; Bae DS; Seo SW
J Gynecol Oncol; 2019 Jul; 30(4):e65. PubMed ID: 31074247
[TBL] [Abstract] [Full Text] [Related]
9. Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma.
Kim YN; Kim M; Ahn HS; Kim K; Park SY; Kim HI; Jeon MJ; Kim WG; Kim SW; Kim WB; Chung JH; Shong YK; Kim TY; Kim TH
Oral Oncol; 2019 Feb; 89():8-13. PubMed ID: 30732964
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract] [Full Text] [Related]
11. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract] [Full Text] [Related]
12. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract] [Full Text] [Related]
13. Expression Patterns of Nrf2 and Keap1 in Ovarian cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
Cho HY; Kim K; Kim YB; Kim H; No JH
Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
[TBL] [Abstract] [Full Text] [Related]
14. Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.
Pereira D; Assis J; Gomes M; Nogueira A; Medeiros R
Eur J Clin Pharmacol; 2016 May; 72(5):545-53. PubMed ID: 26803611
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.
Cui L; Kwong J; Wang CC
J Ovarian Res; 2015 Jun; 8():38. PubMed ID: 26077676
[TBL] [Abstract] [Full Text] [Related]
16. Serum EpCAM expression in pancreatic cancer.
Gebauer F; Struck L; Tachezy M; Vashist Y; Wicklein D; Schumacher U; Izbicki JR; Bockhorn M
Anticancer Res; 2014 Sep; 34(9):4741-6. PubMed ID: 25202052
[TBL] [Abstract] [Full Text] [Related]
17. Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation.
Honda K; Okusaka T; Felix K; Nakamori S; Sata N; Nagai H; Ioka T; Tsuchida A; Shimahara T; Shimahara M; Yasunami Y; Kuwabara H; Sakuma T; Otsuka Y; Ota N; Shitashige M; Kosuge T; Büchler MW; Yamada T
PLoS One; 2012; 7(10):e46908. PubMed ID: 23056525
[TBL] [Abstract] [Full Text] [Related]
18. Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer.
Chekmasova AA; Brentjens RJ
Discov Med; 2010 Jan; 9(44):62-70. PubMed ID: 20102688
[TBL] [Abstract] [Full Text] [Related]
19. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
[TBL] [Abstract] [Full Text] [Related]
